森先特科技
SXT
133.74
+0.32
+0.24%
森先特科技
US · SXT
#2027 按市值排名
上市于 1970
133.74
+0.32
+0.24%
实时 - 追踪5344个代码 - 心跳于233秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
减持
- 最近一期(2026/Q3)披露持股的机构数量减少了1家。
- 机构持股总比例下降了0.6个百分点。
机构持股
- 机构持股比例
- 100.37% -0.61pp
- 机构数量
- 433 -1
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期减持了股份,同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。
机构持股变动数据按季度发布且存在滞后;资金流向数据为每日更新。请将其作为方向性的交叉验证参考,而非精确的择时信号。
持股人类型
Mutual Fund84.09%
Hedge Fund11.29%
Public Company1.87%
Individual/Insider1.62%
Sovereign Wealth Fund1.17%
Government Pension Fund1.15%
Private Company0.35%
Insurance Company0.34%
主要股东 截至 2026-06-30
BlackRock
15.60% · 6.64M 股
Vanguard Portfolio Management, LLC
6.52% · 2.78M 股
Vanguard Capital Management, LLC
5.22% · 2.22M 股
Freemont Capital Pte. Ltd.
4.82% · 2.05M 股
State Street Global Advisors
4.04% · 1.72M 股
Janus Henderson Group plc
4.03% · 1.71M 股
Geode Capital Management, LLC
2.61% · 1.11M 股
Dimensional Fund Advisors
2.49% · 1.06M 股
Vaughan Nelson Investment Management, L.P.
2.37% · 1.01M 股
Congress Asset Management Company, LLP
2.19% · 930.34K 股
条形长度是相对于此处列出的最大股东而言,并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 28次买入 · 18次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Paul Manning | Chairman, CEO, President & Member of Scientific Advisory Committee | 0.66% |
| Stephen Rolfs | Senior Vice President | 0.32% |
| Michael Geraghty | President of Color Group | 0.11% |
| John Manning | Senior Vice President | 0.09% |
| Amy Jones | VP of Human Resources & Senior Counsel | 0.06% |
| Joseph Carleone | Independent Lead Director & Member of Scientific Advisory Committee | 0.06% |
| Deborah McKeithan-Gebhardt | Independent Director & Member of Scientific Advisory Committee | 0.05% |
| Essie Whitelaw | Director & Member of Scientific Advisory Committee | 0.04% |
| Tobin Tornehl | Chief Accounting Officer | 0.04% |
| Thierry Hoang | -- | 0.03% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-29 | Joseph Carleone | Independent Lead Director & Member of Scientific Advisory Committee | Other Derivative Acquisition | +279 | -- |
| 2026-09-29 | Mario Ferruzzi | Independent Director & Member of Scientific Advisory Committee | Other Derivative Acquisition | +42 | -- |
| 2026-08-04 | Mario Ferruzzi | Independent Director & Member of Scientific Advisory Committee | Open Market Disposition | -1,200 | $129.48 |
| 2026-06-30 | Chandrabhushan Singh | -- | Initial Statement of Beneficial | 0 | -- |
| 2026-06-29 | Joseph Carleone | Independent Lead Director & Member of Scientific Advisory Committee | Other Derivative Acquisition | +296 | -- |
| 2026-06-29 | Mario Ferruzzi | Independent Director & Member of Scientific Advisory Committee | Other Derivative Acquisition | +44 | -- |
| 2026-05-17 | Thierry Hoang | -- | Open Market Disposition | -400 | $115.19 |
| 2026-05-03 | Thierry Hoang | -- | Open Market Disposition | -439 | $114.15 |
| 2026-04-29 | Freemont Capital Pte. Ltd. | -- | Open Market Disposition | -2,127,566 | $109.69 |
| 2026-04-29 | Steve Morris | President, Flavors & Extracts Group | Open Market Disposition | -200 | $114.58 |
| 2026-04-22 | Essie Whitelaw | Director & Member of Scientific Advisory Committee | Sale to Issuer | -674 | $99.23 |
| 2026-04-22 | Essie Whitelaw | Director & Member of Scientific Advisory Committee | Other Acquisition | +1,119 | -- |
| 2026-04-22 | Joseph Carleone | Independent Lead Director & Member of Scientific Advisory Committee | Other Acquisition | +1,119 | -- |
| 2026-04-22 | Scott Morrison | Independent Director & Member of Scientific Advisory Committee | Sale to Issuer | -674 | $99.23 |
| 2026-04-22 | Scott Morrison | Independent Director & Member of Scientific Advisory Committee | Other Acquisition | +1,119 | -- |
| 2026-04-22 | Donald Landry | Independent Director & Member of Scientific Advisory Committee | Sale to Issuer | -674 | $99.23 |
| 2026-04-22 | Donald Landry | Independent Director & Member of Scientific Advisory Committee | Other Acquisition | +1,119 | -- |
| 2026-04-22 | Carol Jackson | Independent Director & Member of Scientific Advisory Committee | Sale to Issuer | -674 | $99.23 |
| 2026-04-22 | Carol Jackson | Independent Director & Member of Scientific Advisory Committee | Other Acquisition | +1,119 | -- |
| 2026-04-22 | Mario Ferruzzi | Independent Director & Member of Scientific Advisory Committee | Sale to Issuer | -674 | $99.23 |
Form 4 申报记录,每家公司显示最新的一批。"Other Derivative Acquisition"(其他衍生品获取)类目多为限制性股票/期权归属,并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:05 · 仅供参考,不构成投资建议,也未考虑您的具体情况。
森先特科技 讨论区 0 条评论